Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium

Medicine and Dentistry

• Mycophenolic Acid 55%
• Mycophenolate Mofetil 45%
• Patient 45%
• Follow up 15%
• All Cause Mortality 15%
• Retrospective Study 10%
• Overall Survival 10%
• Graft Survival 10%
• Heart Transplantation 10%
• Antibody Mediated Rejection 10%
• Cells 10%
• Survival Rate 5%
• Prodrug 5%
• Transplantation 5%
• Immunosuppressive Drug 5%
• Chi Square Test 5%
• Log Rank Test 5%
• Age 5%
• Gastrointestinal Distress 5%
• Acute Graft Rejection 5%
• Drug Dose Reduction 5%
• Obstetric Delivery 5%
• Male 5%
• Inpatient 5%
• Organ 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Mycophenolate Mofetil 100%
• All Cause Mortality 15%
• Overall Survival 10%
• Cardiac Allograft Vasculopathy 10%
• Immunosuppressive Agent 5%
• Survival Rate 5%
• Tolerability 5%
• Gastrointestinal Symptom 5%
• Acute Graft Rejection 5%